detected; serum complement concentrations, DNA binding, and urate concentration were within the normal range; a test for hepatitis B surface antigen was negative. Radiography of the hands, neck, and sacroiliac joints showed no abnormality. Tissue type was HLA-B27.
He was treated with indomethacin'50 mg twice daily. One week later the Silastic peritoneal catheter (Tenckhoff) was replaced. Three'weeks later he had an upper gastrointestinal haemorrhage from an acute duodenal ulcer. This did not respond to conservative treatment, and vagotomy and.pyloroplasty were'performed. He had an uneventful postoperative course, though the arthritis persisted for a further week.
Two months later he was stiRl undergoing continuous ambulatory peritoneal dialysis and had had no further episodes of peritoneal infection or acute arthritis.
Comment
The clinical features in this case suggest that the polyarthritis was reactive to the S epidermidis peritoneal infection. The arthritis started three weeks, after the onset of peritonitis and was self-limiting, resolving spontaneously after five weeks. Other known causes of acute arthritis were excluded, and there was no evidence of infection with organisms more commonly associated with reactive arthritis. Furthermore, this patient was positive for HLA-B27, and such individuals are more at risk from this complication. ' 
Lithium-induced constructional dyspraxia
Lithium has a narrow therapeutic range, and the likelihood of serious neurotoxicity and encephalopathy increases as blood concentrations rise above 1-4 mmol(mEq)/l. After'14 days' dosage within the therapeutic range the drug causes subtle cognitive impairment in normal volunteers,' but evidence from controlled studies of chronic administration in patients with manic depression, though conflicting,2 generally suggests that any cognitive changes at normal doses are not clinically important. We report here a case of constructional dyspraxia occurring at lithium concentrations within the therapeutic range after a year's previously uneventful administration.
Case report
A 50 year old housewife presented with endogenous depression of two years' duration. She had had episodes lasting about three months yearly for the previous five years. When first seen she was taking amitriptyline 150 mg a day. The total plasma amitriptyline and nortriptyline concentration of 231 ,&g/l was possibly just above the therapeutic range, but reducing the dose to 125 mg a day did not produce any improvement.
Amitriptyline was stopped and lithium carbonate started, but this did not produce a sustained remission. Thereafter she responded to combined amitriptyline 1295 mg a day and lithium 600 mg a day. After remaining well and taking both drugs for the succeeding 14 months she began to complain of difficulties in finding words in conversation and of memory impairment, in the absence of any recurrence of depressive symptoms. Serum thyroxine concentration and free thyroxine index were normal, as was an electroencephalogram. Her 12-hour lithium concentration was 0*80 mmol/l and during the previous 14 months had ranged from 0 66 to 0-89 mmol/l. Psychological testing showed a Mill Hill verbal IQ of 108 and a progressive matrices performance IQ of 98. Her logical memory, paired associate learning, and memory of an array of pictures were normal both on immediate recall and after 30 minutes' delay. She had difficulty im finding words in ordinary, conversation but not on formal testing for aphasia. A striking abnormality was her inability to copy the Rey picture (score on standard scoring criteria 14 out of 36). These findings indicated appreciable constructional dyspraxia and slight dysphasia.
Lithium was stopped but amitriptyline continued. One month later her word-finding difficulties had disappeared and her copy of the Rey picture (altemative form) was considerably improved, her score being 36 out of 36. There were no appreciable differences in the results of the other tests. She remained affectively well on amitriptyline alone at follow-up after six months.
Comment
These findings indicate slowly developing constructional dyspraxia and mild dysphasia with difficulties of subjective memory occurring at litium concentrations below 10 mmol/l and during concomitant use of amitriptyline. The impairment resolved completely when lithium was stopped and the tricyclic drug continued. Although these side effects may have been due to an interaction of both drugs, lithium and a tricyclic antidepressant are commonly prescribed together and the combination is usually regarded as being safe.
The possibility of cognitive difficulties caused by chronic administration of lithium at concentrations within the therapeutic range has not been discussed in recent reviews of lithium. Cases such as that reported here may be uncommon but nevertheless have practical implications: clinicians unaware of reports of research and particularly those not using the drug frequently may mistake cognitive impairment caused by the drug for a relapse of depression-or early dementia. In ,ases of 'doubt 'formal psychological testing and retesting after the drug has been stopped are indicated. 
Methods and results
Appointment records of the diabetic clinic from 1 January 1979 to 31 May 1980 were studied. Patients who had not attended for 13 months or more were identified, and non-attendance confirmed from the last entry in the hospital notes. If the reason for non-attendance was not apparent information was obtained from the general practitioner directly or by questionnaire.
A total of 972 patients had appointments during the study period. Fortyseven patients (4-8%) were nan-attenders: information was available on 44 (94%), 13 of whom (30%) had in the past missed at least one appointment.
Two of the 44 patients had died. Eighteen patients (12 men, six women; age range 17-78 years, mean 44) had moved to another area or clinic. Five of these patients were on a diet, two were also receiving tablets. The rning 13 were being treated with insulin (mean dose 46 units/day): five of these patients were aged wnder 30 and five were in the age range 30-50. In 14 cases a further appointment was arranged. One patient was pregnant; another was admitted to hospital with self-poisoning.
Ten patients (eight men, two women; age range 18-74, mean 49) were subsequently returned to hospital care. Five were on a diet, two were also receiving tablets. The remaining five were being treated with insulin (mean
